z-logo
Premium
The European Medicines Agency's use of prioritised independent research for best evidence in regulatory action on diclofenac
Author(s) -
Arlett Peter,
Sarac Sinan B.,
Thomson Andrew,
Davies Claire,
Teixeira Tania,
Blake Kevin V.,
Stenver Doris
Publication year - 2014
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.3594
Subject(s) - medicine , diclofenac , agency (philosophy) , pharmacoepidemiology , regulatory agency , pharmacology , action (physics) , public administration , political science , philosophy , physics , epistemology , quantum mechanics , medical prescription

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom